CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 5 enrolled
Drug / intervention
rTMSdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04916444
NCT04916444N/ACompleted
CompareCT.gov

Dystonia Treatment With Injections Supplemented By Transcranial Magnetic Stimulation

University of Florida·interventional·Posted Jun 7, 2021·Updated Oct 8, 2024

In Brief

A clinical study evaluating rTMS for Cervical Dystonia. Completed, enrolled 5 participants across 1 site.

Detailed Summary

We applied 16 sessions of rTMS over 4 consecutive days for adult patients suffering from cervical dystonia who received botulinum toxin (BoNT) injections on a regular basis. The TMS protocol took place 9 weeks following their last BoNT injection. The primary outcome measure was improvement in cervical dystonia as measured by the TWSTRS scale. The secondary outcome measures included mood, cognition, and gait measures.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCervical Dystonia
CountriesUnited States
CollaboratorsDystonia Medical Research Foundation

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJun 7, 2021
Enrollment StartFeb 7, 2022
Primary CompletionDec 20, 2023
Study CompletionJan 7, 2024
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 5.1 years ago

Interventions

rTMSdevice

repetitive transcranial magnetic stimulation is a painless, noninvasive form of neurostimulation. This study uses an accelerated protocol in which the neurostimulation pulses are delivered in 4 sessions per day over 4 consecutive days (16 total sessions). Active or sham rTMS will be provided at 9 weeks following botox injections.